| P2093 | author name string | Gu Zhu | |
| | Qian He | |
| | Erhard Bieberich | |
| | Guanghu Wang | |
| | Michael B Dinkins | |
| | Somsankar Dasgupta | |
| | Ji Na Kong | |
| | Stefka Spassieva | |
| | Austin Kim | |
| P2860 | cites work | Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2 | Q24316869 |
| | ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models | Q24628845 |
| | Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance | Q26865927 |
| | Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions | Q27008452 |
| | Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance | Q27437985 |
| | Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells | Q28486164 |
| | Ceramide triggers budding of exosome vesicles into multivesicular endosomes | Q29616811 |
| | Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Q33194199 |
| | The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. | Q33222111 |
| | Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines | Q33310534 |
| | Side population cells in human cancers | Q33335585 |
| | Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease | Q33670207 |
| | Xenobiotic, bile acid, and cholesterol transporters: function and regulation. | Q33714593 |
| | Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer | Q33870504 |
| | Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) | Q34176588 |
| | Breast cancer, side population cells and ABCG2 expression | Q34240976 |
| | Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines | Q34409198 |
| | Multivesicular bodies and multivesicular endosomes: the "ins and outs" of endosomal traffic | Q34745140 |
| | Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. | Q35161115 |
| | Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia | Q35879557 |
| | MS-209 Schering. | Q36008454 |
| | Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). | Q36033271 |
| | Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 |
| | Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells | Q36600615 |
| | IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression | Q36812342 |
| | Breast cancer stem cells: implications for therapy of breast cancer. | Q36955061 |
| | Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide | Q37131369 |
| | Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential | Q37184737 |
| | Targeting vesicle trafficking: an important approach to cancer chemotherapy. | Q37185347 |
| | Cancer stem cells: how can we target them? | Q37347253 |
| | The guggul for chronic diseases: ancient medicine, modern targets | Q37384437 |
| | The gut-to-breast connection - interdependence of sterols and sphingolipids in multidrug resistance and breast cancer therapy | Q37894763 |
| | Microparticles and their emerging role in cancer multidrug resistance. | Q37901204 |
| | Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. | Q37958162 |
| | Breast cancer stem cells: a novel therapeutic target | Q38057826 |
| | Breast cancer stem cells: an update | Q38074394 |
| | Exosomes in tumor microenvironment influence cancer progression and metastasis | Q38091978 |
| | Extracellular vesicles: biology and emerging therapeutic opportunities. | Q38098874 |
| | ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. | Q38107993 |
| | The network of P-glycoprotein and microRNAs interactions | Q38152293 |
| | Cellular communication via microparticles: role in transfer of multidrug resistance in cancer | Q38206278 |
| | Extracellular vesicles as modulators of the cancer microenvironment. | Q38348123 |
| | Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release | Q39413836 |
| | Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions | Q39460366 |
| | Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. | Q39860485 |
| | High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. | Q39953729 |
| | Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells | Q40065594 |
| | Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas | Q40169778 |
| | Lipids isolated from bone induce the migration of human breast cancer cells | Q40324408 |
| | Increase of ceramide in adriamycin-induced HL-60 cell apoptosis: detection by a novel anti-ceramide antibody | Q44183914 |
| | The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma | Q46493507 |
| | Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure | Q46864895 |
| | Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma. | Q54524230 |
| | Development and characterization of a novel anti-ceramide antibody | Q57375071 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (E)-guggulsterone | Q10910387 |
| | doxorubicin | Q18936 |
| P304 | page(s) | 1610-1620 | |
| P577 | publication date | 2015-04-27 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells | |
| P478 | volume | 137 | |